caffeine has been researched along with Abnormal Movements in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Caffeine was overall well tolerated, even in children, and 87% of patients reported a clear improvement." | 1.72 | Efficacy of Caffeine in ADCY5-Related Dyskinesia: A Retrospective Study. ( Anheim, M; Barth, M; Cif, L; Damier, P; DeGusmao, C; Demonceau, N; Doulazmi, M; Doummar, D; Friedman, J; Gallea, C; Gras, D; Gurgel-Giannetti, J; Innes, EA; Méneret, A; Mohammad, SS; Necpál, J; Paramanandam, V; Pringsheim, T; Riant, F; Roze, E; Sagnes, S; Sarret, C; Seliverstov, Y; Shetty, K; Tranchant, C; Vidailhet, M, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Di Rocco, M | 1 |
| Galosi, S | 1 |
| Lanza, E | 1 |
| Tosato, F | 1 |
| Caprini, D | 1 |
| Folli, V | 1 |
| Friedman, J | 2 |
| Bocchinfuso, G | 1 |
| Martire, A | 1 |
| Di Schiavi, E | 1 |
| Leuzzi, V | 1 |
| Martinelli, S | 1 |
| Méneret, A | 2 |
| Mohammad, SS | 1 |
| Cif, L | 1 |
| Doummar, D | 1 |
| DeGusmao, C | 1 |
| Anheim, M | 1 |
| Barth, M | 1 |
| Damier, P | 1 |
| Demonceau, N | 1 |
| Gallea, C | 1 |
| Gras, D | 2 |
| Gurgel-Giannetti, J | 1 |
| Innes, EA | 1 |
| Necpál, J | 1 |
| Riant, F | 1 |
| Sagnes, S | 1 |
| Sarret, C | 1 |
| Seliverstov, Y | 1 |
| Paramanandam, V | 1 |
| Shetty, K | 1 |
| Tranchant, C | 1 |
| Doulazmi, M | 1 |
| Vidailhet, M | 1 |
| Pringsheim, T | 1 |
| Roze, E | 2 |
| Tänzler, D | 1 |
| Kipping, M | 1 |
| Lederer, M | 1 |
| Günther, WF | 1 |
| Arlt, C | 1 |
| Hüttelmaier, S | 1 |
| Merkenschlager, A | 1 |
| Sinz, A | 1 |
| McGovern, E | 1 |
| Weisz, CJ | 1 |
| Raike, RS | 1 |
| Soria-Jasso, LE | 1 |
| Hess, EJ | 1 |
| Bové, J | 1 |
| Serrats, J | 1 |
| Mengod, G | 1 |
| Cortés, R | 1 |
| Aguilar, E | 1 |
| Marin, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pilot Study on Subjective Efficiency of Caffeine in ADCY5-related Dyskinesia[NCT04351360] | 20 participants (Anticipated) | Observational | 2020-04-10 | Not yet recruiting | |||
| Study of Caffeine Efficacy in ADCY5-related Dyskinesia - a Retrospective Study[NCT04469283] | 20 participants (Anticipated) | Observational | 2020-07-15 | Not yet recruiting | |||
| Phase 2 Study of 4-Aminopyridine for the Treatment of Episodic Ataxia Type 2[NCT01543750] | Phase 2 | 0 participants (Actual) | Interventional | Withdrawn | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 other studies available for caffeine and Abnormal Movements
| Article | Year |
|---|---|
Caenorhabditis elegans provides an efficient drug screening platform for GNAO1-related disorders and highlights the potential role of caffeine in controlling dyskinesia.
Topics: Acetylcholinesterase; Animals; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Caffeine; Dr | 2022 |
Efficacy of Caffeine in ADCY5-Related Dyskinesia: A Retrospective Study.
Topics: Adenylyl Cyclases; Caffeine; Child; Dyskinesias; Humans; Movement Disorders; Retrospective Studies | 2022 |
Effects of theophylline on ADCY5 activation-From cellular studies to improved therapeutic options for ADCY5-related dyskinesia patients.
Topics: Bronchodilator Agents; Caffeine; Child, Preschool; Diuretics; Dyskinesias; Humans; Phosphodiesterase | 2023 |
Caffeine and the Dyskinesia Related to Mutations in the ADCY5 Gene.
Topics: Adenylyl Cyclases; Caffeine; Child; Dyskinesias; Humans; Madagascar; Male; Mutation | 2019 |
Caffeine and the Dyskinesia Related to Mutations in the ADCY5 Gene.
Topics: Adenylyl Cyclases; Caffeine; Child; Dyskinesias; Humans; Madagascar; Male; Mutation | 2019 |
Caffeine and the Dyskinesia Related to Mutations in the ADCY5 Gene.
Topics: Adenylyl Cyclases; Caffeine; Child; Dyskinesias; Humans; Madagascar; Male; Mutation | 2019 |
Caffeine and the Dyskinesia Related to Mutations in the ADCY5 Gene.
Topics: Adenylyl Cyclases; Caffeine; Child; Dyskinesias; Humans; Madagascar; Male; Mutation | 2019 |
Potassium channel blockers inhibit the triggers of attacks in the calcium channel mouse mutant tottering.
Topics: 4-Aminopyridine; Analysis of Variance; Animals; Behavior, Animal; Caffeine; Calcium Channels, N-Type | 2005 |
Reversion of levodopa-induced motor fluctuations by the A2A antagonist CSC is associated with an increase in striatal preprodynorphin mRNA expression in 6-OHDA-lesioned rats.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adenosine; | 2006 |